Xspray Pharma AB (publ)

kr 10.80As of Sun 8 Nov 2026, 12:00 UTC
STO:XSPRAYHealthcare
Country Sweden
PE (Fwd) •••
TSR 9Y CAGR (10.98%)
Div yield —
ROE (24.44%)
Biotechnology
Beta (5Y) 0.01
PE TTM —
TSR TTM (56.79%)
Mkt cap kr 512.1M
ROIC (11.36%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 13
17.43%
62.70%
Hold 9|11|4|1|5
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.10
0.12
0.12
0.13
(5.01%)
8.99%
19.86%
28.17%
Revenuekr M
53.54
54.47
54.19
54.37
2.12%
2.62%
(2.19%)
(1.19%)
Peers (US$51.77M)
Cap (US$)
PE
45.75M
2.402x
Capital
TTM
5Y
10Y
Leveragex
0.461
(1.825)
(1.444)
EBIT/Intx
2.913
0.283
0.253
Own earn%
(39.61)
(110.11)
(86.33)
Sh yield%
44.00
19.79
22.44
Owners
Insiders/Inst%
14.50
26.30
Short interest%
4.69
SBC / revenue%
5.23
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
17–27
$1 testx
—
Incr. ROIC%
14